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Induction of autophagy is known not only to regulate cellular homeostasis but also to decrease triglyceride accumulation
in hepatocytes. The aim of this study is to investigate whether DMSO (dimethyl sulfoxide) has a beneficial role in free
fatty acid-induced hepatic fat accumulation.
In HepG2 cells, treatment with 0.5 mM palmitate for six hours significantly increased lipid and triglyceride (TG)
accumulation, assessed by Oil-red O staining and TG quantification assay. Treatment with 0.01% DMSO for 16 h
statistically reduced palmitate-induced TG contents. Pretreatment of 10 mM 3-methyladenine (3MA) for 2 h restored
hepatocellular lipid contents, which were attenuated by treatment with DMSO. DMSO increased LC3-II conversion and
decreased SQSTM1/p62 expression in a time and dose-dependent manner. In addition, the number of autophagosomes
and autolysosomes, as seen under an electron microscopy, as well as the percentage of RFP-LAMP1 colocalized with GFP-
LC3 dots in cells transfected with both GFP-LC3 and RFP-LAMP1, as seen under a fluorescent microscopy, also increased
in DMSO-treated HepG2 cells. DMSO also suppressed p-eIF2a/p-EIF2S1, ATF4, p-AKT1, p-MTOR and p-p70s6k/p-RPS6KB2
expression as assessed by western blotting. Knockdown of ATF4 expression using siRNA suppressed ATF4 expression and
phosphorylation of AKT1, MTOR and RPS6KB2, but increased LC3-II conversion. DMSO reduced not only soluble but also
insoluble mtHTT (mutant huntingtin aggregates) expressions, which were masked in the presence of autophagy
inhibitor. DMSO, a kind of chemical chaperone, activated autophagy by suppressing ATF4 expression and might play a
protective role in the development of fatty acid-induced hepatosteatosis.
Introduction
Although the primary cause of the accumulation of various lipids
in the liver is not yet clear, an increased supply of free fatty acids,
de novo hepatogenic lipogenesis, decreased oxidation of free
fatty acids, and secretion of hepatic VLDL (very low density
lipoprotein-triglyceride) have been implicated in the development
of nonalcoholic fatty liver disease (NAFLD).1,2 In this regard,
NAFLD may be a separate disease with a different pathogenesis,
and developing a new molecular model thereof is essential
in adequate management of NAFLD or NASH (nonalcoholic
steatohepatitis).3,4 Among the practical medical treatments of
NAFLD, taurine-conjugated ursodeoxycholic acid (UDCA),
known as a chemical chaperone, resulted in the resolution of
fatty liver disease and enhancement of insulin action in the liver.5
Recent studies have shown that macroautophagy (henceforth
referred to as autophagy) functions within hepatocytes to eliminate
misfolded proteins6 as well as to degrade hepatocellular triglyceride
accumulation.7-9 Based on these reports, we hypothesized that
stored fat could be decreased not only through inhibition of
lipogenesis but also through clearance of hepatocellular lipids.
Therefore, we investigated whether dimethyl sulfoxide (DMSO), a
member of the group of compounds with low molecular weight
called chemical chaperones,10 has a beneficial role in reducing free
fatty acid-induced hepatic fat accumulation.
Results
DMSO reduces lipid accumulation in hepatocytes. DMSO was
reported to induce cytotoxicity.11,12 In this regard, we performed
an MTT assay to determine the relative proliferation or viability
(presented as the percentage of untreated control) of a human
hepatoma cell line (HepG2 cells) after 24 h of DMSO (0, 0.005,
0.01, 0.05, 0.1, 0.5, 1.0 and 5.0%) treatment. DMSO at
concentrations of 0.005 to 0.1% proved beneficial to prolifera-
tion, but proliferation decreased for concentration at or higher
than 0.5% with significance at the concentration of 5% (82.39 ±
1.07, p , 0.01) (Fig. 1A). HepG2 cells exposed to 0.5 mM
palmitate for 24 h showed significantly decreased cell proliferation
(68.52 ± 3.03, p , 0.001). Pre-treatment with 0.01, 0.05, 0.1,
0.5 and 1.0% DMSO for 16 h partially alleviated the palmitate-
induced HepG2 cell toxicity with significance (Fig. 1B).
Intracellular lipid accumulation was analyzed by microscopy
after staining with cells with Oil red O (ORO), and quantification
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Figure 1. DMSO reduces lipid accumulation in hepatocytes proliferation and lipid accumulation of HepG2 cells after treatment with DMSO in the absence
or presence of palmitate. (A) In the MTT assay, relative proliferation (presented as % of untreated control) of HepG2 cells exposed to DMSO for 24 h
decreased at higher than 0.5%: 96.82 ± 1.72% with 0.5%, 92.15 ± 5.25 with 1.0% and 82.39 ± 1.07 with 5.0% (p , 0.01). (B) HepG2 cells exposed to
0.5 mM palmitate for 24 h showed significantly decreased cell proliferation (68.52 ± 3.03, p , 0.0 01), and pre-treatment with 0.01, 0.05, 0.1, 0.5 and 1.0%
DMSO for 16 h partially prevented palmitate-induced HepG2 cell toxicity with significance. Results are representative of eight independent experiments.
(C and D) In microscopy staining of cells with Oil red O and a spectrophotometer analysis, treatment with 0.5 mM palmitate increased lipid accumulation,
but pretreatment with 0.01% DMSO before 0.5 mM palmitate exposure significantly reduced free fatty acid-induced lipid content. (E) In triglyceride
determination, pretreatment with 0.01% DMSO also partially restored free fatty acid-induced triglyceride (TG) accumulation (66.01 ± 5.40 vs. 51.48 ± 2.75
p , 0.001). The experiments were performed six times to determine MTT and ORO as well as TG under identical conditions. The results are shown as
mean ± SEM *p , 0.05, **p , 0.01, ***p , 0.001 vs. untreated control cells. †p , 0.05, ††p , 0.01,†††p , 0.001 vs. palmitate-treated cells.
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using a spectrophotometer at 520 nm. Since triglyceride (TG) is
the major component of the lipid droplets, we also checked the
TG content of the cells in this experiment. Thereby, we could
observe visible lipid droplets in cells incubated with palmitate
(Fig. 1C). Compared with the untreated controls, HepG2 cells
treated with 0.01% DMSO for 16 h showed minimally decreased
assessable lipid content (0.23 ± 0.01 vs. 0.21 ± 0.003) without
statistical significance as assessed by fat quantization with ORO
(Fig. 1D). HepG2 cells exposed to 0.5 mM palmitate for 6 h
showed significantly increased lipid accumulation (0.23 ± 0.01 vs.
0.40 ± 0.02. p , 0.001) and TG determination (34.98 ± 5.76 vs.
66.01 ± 5.40 p , 0.001) (Fig. 1D and E). Pretreatment with
0.01% DMSO before exposure to 0.5 mM palmitate for 6 h
also partially inhibited free fatty acid-induced lipid contents
(0.40 ± 0.02 vs. 0.35 ± 0.02, p , 0.001) and TG accumulation
(66.01 ± 5.40 vs. 51.48 ± 2.75 p , 0.001) with significance,
suggesting a limited modulating role among different lipogenic
and lipid clearance pathways.
DMSO induces autophagy. To elucidate the possible mecha-
nism of macrolipophagy-mediated clearance of lipid droplets,7
steps of autophagy that can be monitored were performed. First,
LC3 (microtubule-associated protein 1 light chain 3)-II conver-
sion of HepG2 cells treated with 0.01 to 1.0% DMSO for 16 h
was increased in a dose-dependent manner, monitored by western
Figure 2. DMSO induces autophagy DMSO modulates the expression of the autophagy. (A) In monitoring the induction steps of autophagy, assessed by
LC3-I conversion to LC3-II, converted LC3-II expressions were increased in a dose-dependent manner as 0.01 to 1.0% DMSO treatment concentration
for 16 h increased. (B) HepG2 cells treated with 0.005 and 0.01% DMSO for 8 and 16 h showed decreased SQSTM1 expression and increased LC3-II
conversion in a time-dependent manner. Results are representative of five independent experiments. In LC3 flux assays by immunoblot, in the absence
or presence of 50 mM chloroquine (CQ, lysosomal inhibitors), DMSO increased the LC3-II conversion in a time (0, 8, 16 and 24 h) and dose (0, 0.005, 0.01)-
dependent manner, and chloroquine further upregulated LC3-II expression in the same manners (B, lower panel). (C) The level of mRNA expression of LC3
was also increased by DMSO treatment in a dose- and time-dependent manner. Results are representative of three independent experiments. Results are
shown as mean ± SEM *p , 0.05, ***p , 0.001 vs. untreated control cells, †p , 0.05 vs. 0.005% DMSO-treated cells. (D) For monitoring of the vesicle
formation step of autophagy and autophagosomes-lysosome fusion, assessed by fluorescence microscopic assay, colocalized punctate patterns of
autophagy marker GFP-LC3 and RFP-LAMP1 were increased in response to autophagic induction d by 0.01% DMSO. (E) An excessive number of dots
appeared in DMSO-treated cells in view of controls (6.86 ± 4.37 vs. 23.38 ± 16.32, p, 0.05). The experiments were performed seven times under identical
conditions. In transmission electron microscopy, ultrastructure of HepG2 cells treated with 0.01% DMSO for 16 h was analyzed. Arrow heads,
autophagosome; arrows, autolysosome; asterisks, curved phagophore.
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blotting (Fig. 2A). HepG2 cells exposed to 0.05 and 0.1%
DMSO for 8 to 16 h were shown to increase LC3-II conversion
and decrease SQSTM1/p62 (hereafter SQSTM1) in a dose- and
time-dependent manner (Fig. 2B). Second, we tested for whether
increased DMSO could be due to either the induction of
autophagy or the inhibition of lysosomal degradation by using
autophagic flux assay. In the presence of 50 mM lysomal inhibitor
chloroquine, more decrease in SQSTM1 expression and increased
expression of LC3-II conversion were found in a time- and
dose-dependent manner than by DMSO alone (Fig. 2B). To
determine the RNA levels of LC3, we employed reverse
transcription polymerase chain reaction (RT-PCR). Time and
dose-dependent expression of LC3 transcription was also found
in HepG2 cells treated with 0.01% DMSO (Fig. 2C). Third,
HepG2 cells were infected with a specific autophagic marker
GFP-LC3 (comprising green fluorescent protein fused to the
N-terminus of LC3), and visualized by fluorescence microscopy.
As presented in Figure 2D, a punctate pattern of GFP-LC3
accumulated upon the challenge with 0.01% DMSO, an excessive
number of dots appeared in DMSO-treated cells compared the
control groups (6.86 ± 4.37 vs. 23.38 ± 16.32, p , 0.05).
In addition, HepG2 cells were also co-transfected with both GFP-
LC3 and RFP-LAMP1 (lysosome associated membrane protein
1-tagged with red fluorescent protein) and then treated with
0.01% DMSO for 16 h. Fluorescence microscopy showed RFP-
LAMP1 colocalized with GFP-LC3 in the cytoplasm. Finally,
one pathognomonic feature of autophagy is the ultrastructural
evidence of autophagosomes. We ultimately examined DMSO-
treated HepG2 cells using an electron microscope to confirm the
induction of autophagy. Figure 2E shows that after 16 h of
exposure to 0.01% DMSO autophagosomes and autolysosomes
are abundantly present.
Figure 2D and E. See previous page for figure legend.
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Inhibition of autophagy blocks DMSO-induced reduction of
lipid accumulation. In order to verify the hypothesis stating that
DMSO could attenuate free fatty acid-induced lipid accumulation
via macrolipophagy induction, we investigated its autophagic
role in the presence or absence of (1) MG132 for ubiquitin-
proteasome inhibition, (2) 3-methyladenie (3MA) for autophagy
inhibition, and (3) chloroquine for lysosomal inhibition. Similar
to previous results, in Figure 1D and E, 0.5 mM palmitate at 6 h
significantly increased lipid accumulation; however, 0.01%
DMSO partially attenuated palmitate-induced lipid accumula-
tion (Fig. 3A and B). In the treatment of MG132, a potent
membrane-permeable proteasome inhibitor, no statistical differ-
ence in lipid accumulation was found between cells treated with
palmitate + DMSO and those with palmitate + DMSO + MG132
(0.34 ± 0.05 vs. 0.35 ± 0.06, p . 0.05), suggesting no
involvement of proteasome on the lipid reducing effects of
DMSO. In the treatment of 3-MA, which inhibits autophagy by
blocking autophagosome formation via the inhibition of type III
phosphatidylinositol 3-kinases (PtdIns3K) at the sequestration
stage, where a double-membrane structure forms around a portion
of the cytosol and sequesters it from the rest of cytoplasm to form
the autophagosomes,13 a significant difference in lipid content was
found between cells treated with palmitate + DMSO and those
with palmitate + DMSO + 3-MA (0.35 ± 0.02 vs. 0.42 ± 0.01,
p , 0.001). Chloroquine is known to accumulate in lysosomes
due to its weak base properties and inhibit the lysosomal pathway
of protein degradation. There was a significant difference in lipid
content between cells treated with palmitate + DMSO and those
treated with palmitate + DMSO + chloroquine (0.42 ± 0.01 vs.
0.56 ± 0.05, p , 0.001).
DMSO reduces expression of ER stress markers and induces
autophagy. To elucidate the hypothesis stating that down-
regulation of an unfolded protein response or ER stress markers,
such as GRP78/HSPA5 (hereafter HSPA5), p-PERK/p-EIF2AK3
(hereafter EIF2AK3), p-eIF2a/p-EIF2S1 (hereafter p-EIF2S1),
ATF4, ATF6, p-IRE1/p-ERN1 (hereafter p-ERN1), sXBP1 and
CHOP/DDIT3 (hereafter DDIT3) by DMSO, would induce
autophagy, with DMSO acting as a chemical chaperone, western
blotting assay was performed. In the absence of a stressor, DMSO
inhibited upstream of unfolded protein response or ER stress
pathway, such as phosphorylation of p-EIF2AK3, EIF2S1 and the
expression of ATF4, ATF6, p-AKT1 and p-MTOR in a time- and
dose-dependent manner (Fig. 4A). Similar to previous reports on
palmitate-induced increased expression of ER stress markers in
various cell lines,14-16 HepG2 cells exposed to 0.5 mM palmitate
for 6 h significantly activated HSPA5, p-EIF2AK3, p-EIF2S1,
ATF4, ATF6, p-ERN1, sXBP1 and DDIT3 with significance
(Fig. 4A and B). Regarding upregulated LC3II conversion as a
self-protecting mechanism in our hypothesis, autophagy induc-
tion might be upregulated in response to ER stress, which could
be also considered as a stressor marker. As expected, 0.01%
DMSO efficiently inhibited palmitate-induced ER stress marker
(Fig. 4B and C). Of the ER stress markers, EIF2S1 phosphoryla-
tion is also known to be a critical part of the PtdIns3K/AKT1/
MTOR/ RPS6KB2 pathway, which may regulate either auto-
phagy induction or suppression.17 The downstream target of
phophorylated EIF2S1 is ATF4, and knockdown of ATF4
expression can induce autophagy.18 As shown in Figure 4B and
D, 0.01% DMSO reduced the expression of phophorylated
EIF2S1, ATF4, p-AKT1, p-MTOR and p-RPS6KB2, resulting
in activated LC3II conversion and increased autophagy flux as
confirmed by decreased levels of SQSTM1. As seen in Figure 4B
and D, decreased expression of SQSTM1 in the presence of
0.5 mM palmitate alone was further decreased by addition of
DMSO.
DMSO-induced autophagy is controlled through ATF4-
mediated downregulation of phosphorylated AKT1. To deter-
mine the pivotal role of ATF4 in DMSO-induced autophagy, we
tested the RNA levels of ATF4 using reverse transcription
polymerase chain reaction (RT-PCR). As shown in Figure 5A
and B, a time- and dose-dependent significant suppression of
ATF4 in protein and mRNA levels was found in HepG2 cells
treated with 0.01% DMSO treatment. We also investigated its
effects under ATF4 knockdown conditions. We transfected
HepG2 cells with siRNA molecules against ATF4 and then
incubated them in the presence or absence of palmitate. As shown
in Figure 5C and D, siRNA against ATF4 significantly increased
LC3-II conversion. We also found that in the presence of
chloroquine (1.0 ± 0.0 vs. 4.62 ± 0.99, p, 0.001), the expression
of LC3-II was further increased than by siATF4 alone (1.0 ± 0.0
vs. 3.21 ± 0.48, p , 0.001) (Fig. 5D).
We checked the effect of ATF4 silencing on autophagy by
detecting LC3-II using western blot. As shown in Figure 5E,
treatment with ATF4 siRNA decreased the expression of ATF4,
p-AKT1, p-MTOR and p-RPS6KB2, significantly in ATF4
(1.0 ± 0.0 vs. 0.57 ± 0.05, p , 0.001), p-AKT1 (1.0 ± 0.0 vs.
0.56 ± 0.09, p, 0.001) and p-MTOR (1.0 ± 0.0 vs. 0.67 ± 0.24,
p , 0.05). However, the same treatment significantly increased
the expression of LC3-II (1.0 ± 0.0 vs. 1.54 ± 0.27, p , 0.05).
The knockdown of ATF4 attenuates the palmitate-induced
lipid accumulations. Intracellular lipid accumulation was
analyzed using a spectrophotometer at 520 nm under ATF4
knockdown conditions. siRNA against ATF4 significantly
attenuated palmitate-induced lipid accumulation (0.098 ± 0.008
vs. 0.076 ± 0.009, p , 0.001) in Figure 5F.
The aggregation of polyglutamine was reduced by DMSO-
induced autophagy. To confirm whether the DMSO-induced
autophagy can also degrade protein aggregates, we established a
cell-based functional assay using a GFP-fused segment of HTT
exon1 containing expanded polyglutamine (n = 120).19,20 The
transfection of pHTTex120Q-GFP (mtHTT) into cells alone
could induce the expression of dot-like aggregates in HepG2 cells.
As shown in Figure 6A, we found the aggregation and localization
of GFP-fused mtHTT in HepG2 cells under fluorescence
microscope. To elucidate whether chemical chaperones leads to
alleviation in mtHTT aggregation in HepG2 cells, we explored
the effect of DMSO on mtHTT aggregates. Cells were also
transfected with pcDNA (PCD) as a negative control. We
separated polyglutamine aggregates to separate mtHTT aggregates
into detergent-soluble and insoluble fraction and quantify
the level of soluble and insoluble mtHTT proteins. As seen
in Figure 6B, DMSO significantly alleviated insoluble mtHTT
www.landesbioscience.com Autophagy 1089
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Figure 3. Inhibition of autophagy blocks the effects of DMSO that reduces lipid accumulation. Lipid accumulation was determined by fat quantization in
the presence or absence of the ubiquitin-proteasome inhibitor (MG132), the specific autophagy inhibitor (3-methyladenie, 3MA) and the lysosomal
inhibitor (chloroquine, CQ). These inhibitors were pretreated for 2 h and then 0.01% DMSO added to each wells. (A and B) After treatment of 0.01%
DMSO for 16 h, HepG2 cells were exposed 0.5 mM palmitate for 6 h. Palmitate-treated HepG2 cells (0.5 mM for 6 h) exhibited a significant increase in
lipid accumulation. Compared with cells treated with palmitate and DMSO, no statistical difference in the treatment of 1 mM MG132 was observed.
Treatment of 10 mM 3MA or 50 mM chloroquine in the presence of DMSO and palmitate significantly increased lipid content. The lipid content of
cells treated with palmitate + 3MA were similar to those of cells treated with palmitate alone. (B) The lipid content of cells treated with palmitate +
chloroquine were significantly higher than those of cells treated with palmitate alone were (0.57 ± 0.05 vs. 0.46 ± 0.05, p , 0.001). Results are
representative of five independent experiments. Results are shown as mean ± SEM ***p , 0.001 vs. untreated control cells, †p , 0.05, ††p , 0.01,
†††p , 0.01 vs. palmitate-treated cells, 444p , 0.01 vs. palmitate and DMSO-treated cells.
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expression (1.0 ± 0.0 vs. 0.88 ± 0.12, 0.38 ± 0.11, 0.11 ± 0.08,
p , 0.001 for 0.02% DMSO and pcDNA), which were not
found in the presence of 3-methyladenie (3MA) (1.21 ± 0.09 vs.
1.18 ± 0.17, 1.04 ± 0.31, 0.05 ± 0.023). Autophagy flux assessed
by SQSTM1 was decreased by treatment with DMSO.
Discussion
In a human disease model, inactivation of autophagy results in
cytosolic protein inclusions, such as misfolded proteins and excess
accumulation of damaged organelles, which lead to liver injury
and other diseases.21 It has recently become known that
autophagy mediates the elimination of stored lipid droplets and
that inhibition of autophagy leads to the development of
hepatosteatosis.7-9,22 Based on these findings, Singh et al.
described the process of cellular lipid storage and the autophagic
machinery allowing the targeting of a lipid cargo by lysosomes for
degradation as macrolipophagy.7,9 In view of these facts, our
attention was drawn to the antilipotoxic effects of chemical
chaperones on clearing fat droplet accumulation in human
hepatocellular carcinoma cells.
We hypothesized that DMSO (dimethyl sulfoxide) activates
induction of autophagy, or so called macrolipophagy via down-
regulation of the ATF4/AKT1 pathway.5 First, we observed that
the proliferation or viability of HepG2 cells treated with DMSO
for 24 h proved beneficial to proliferation, as assessed by MTT, at
low concentrations (0.005 to 0.1%), but showed decreased
proliferation at concentrations higher than 0.5%. Although MTT
assay is generally used to indicate cell proliferation and cell death,
it is mainly a mitochondrial functional assay. In this regard, we
postulated that DMSO at low concentrations might play a
protective role on the mitochondria and cell proliferation. Next,
when we evaluated its attenuating effects on lipid accumulation
using oil red O staining and TG quantification assay, we found
that pretreatment with 0.01% DMSO before 0.5 mM palmitate
exposure significantly reduced free fatty acid-induced lipid
content and TG accumulation, while untreated controls did not
show such reduction. In addition, this attenuation of palmitate-
induced lipid accumulation by DMSO could not be observed in
the presence of 3-methyladenine. These results suggest that
treatment of DMSO partially attenuates lipid accumulation in
human hepatocellular carcinoma cell lines. To differentiate
whether or not DMSO enhances autophagy-dependent degrada-
tion, we verified the induction of autophagy through autophagy
monitoring (related LC3 binding protein turnover assays for the
induction steps of autophagy and SQSTM1) in the absence or
presence of lysosomal inhibitors chloroquine, fluorescence
microscopy for colocalization of the GFP-LC3 and RFP-
LAMP1 punctate, and electron microscopy for detection of
autophagosomes and autolysosomes.
Chemical chaperones were reported to alleviate ER stress.23,24
In accordance with the cytoprotective effects of a chemical
chaperones, treatment with DMSO decreased the expression of
ER stress markers even in the absence of stress (Fig. 4A). As
expected, exposure to 0.5 mM palmitate for 6 h significantly
activated HSPA5, p-EIF2AK3, p-EIF2S1, ATF4, ATF6,
p-ERN1, sXBP1 and DDIT3. Similar to previous reports on
ER stress-induced autophagy induction across various cell types
including yeast and mammalian cells, 0.5 mM palmitate not only
caused ER stress but also upregulated autophagy flux confirmed
by increased LC3-II conversion and decreased expression of
SQSTM1 in this study (Fig. 4B). We postulated that the
induction of autophagy in this condition might be considered
as a self-protective mechanism against cell stress. Among the ER
stress makers, phosphorylation of EIF2S1 increases and enables
translation of ATF4 in response to unfolded protein response and
ER stress, and the suppression of EIF2S1 phosphorylation
efficiently decreases the level of phospho-AKT1, which regulates
MTOR activity and its autophagy induction.17,25 Treatment with
0.01% DMSO significantly inhibited palmitate-induced ER stress
Figure 4. DMSO reduces expression of ER stress markers and induces
autophagy effects of DMSO on cultured HepG2 cells. (A) In western
blotting assays, DMSO downregulated the expression of ER stress
markers in a time- and dose-dependent manner. (B and C) DMSO inhibits
palmitate-induced ER stress markers. HepG2 cells exposed to 0.5 mM
palmitate showed significant increase in ER stress markers (HSPA5,
p-EIF2AK3, p-EIF2S1, ATF4, ATF6, p-ERN1, sXBP1 and DDIT3).
Pretreatment of 0.01% DMSO significantly reduced palmitate-induced ER
stress. (D) DMSO reduced the expression of phosphorylated EIF2S1,
ATF4, p-AKT1, p-MTOR and p-RPS6KB2 resulting in activated LC3II
conversion and decreased levels of SQSTM1. These experiments were
performed four times under identical conditions. Results are shown
as mean ± SEM **p , 0.01, ***p , 0.001 vs. untreated control cells.
†p , 0.05, ††p , 0.01, †††p , 0.01 vs. palmitate-treated cells.
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markers and augmented the LC3-II conversion via suppression of
p-EIF2S1, ATF4, p-AKT1 and p-MTOR in this study (Fig. 4D).
We hypothesized that downregulation of ATF4 by DMSO might
play an essential role in inducing autophagy. To test this
hypothesis, we demonstrated the dose and time-dependent
suppression of ATF4 by DMSO in protein and m-RNA levels
(Fig. 5A and B). Knockdown of ATF4 expression using siRNA
significantly suppressed expression of ATF4, p-AKT1, p-MTOR
and RPS6KB2 but increased LC3-II conversion (Fig. 5E).
However, the knockdown effects of ATF4 siRNA did not
attenuate the phosphorylation of EIF2S1. These results could
support our hypothesis that ATF4 inhibition is an important
mechanism for lipid clearance in free fatty acid-induced lipid
accumulation. Concerning the expression of p-AKT1 in the
p-AKT1/MTOR pathway, it is known that expression of p-AKT1
is increased in the early phase of exposure, and decreased in
prolonged exposure to palmitate, while that of MTOR is
increased in a time- and dose-dependent manner. In this regard,
we postulated that the induction of macrolipophagy by DMSO
might be different from that achieved by palmitate. And we tried
to confirm the autophagy-mediated lipid clearance mechanism.
Our results showed that the treatment of HepG2 cells with
DMSO reduced palmitate-induced lipids, but in the presence of
the specific autophagy inhibitor 3-methyladenine (3MA), treat-
ment with DMSO did not reduced the amount of lipid. In
addition, UPS (ubiquitin/proteasome system) is known to play a
major role in the highly regulated extralysosomal degradation of
cytosolic proteins and of proteins residing in the nucleus and
endoplasmic reticulum in eukaryotic cells.26 Since there was no
difference in lipid accumulation in cells treated with MG132 in
the presence of palmitate and DMSO, we suggest that the
potential proteasomal inhibition of DMSO might be actually
negligible. Taken together, our results suggest that DMSO
attenuated lipid accumulation through activation of the macro-
lipophagy pathway, which appears to be one of the possible
mechanisms by which DMSO attenuates free fatty acid-induced
cellular lipotoxicity.
There may be considerable debate as to whether the ability
of DMSO is specifically beneficial for removing free fatty
acid-induced hepatic lipid accumulation or is also applicable in
Figure 4B–D. See previous page for figure legend.
1092 Autophagy Volume 8 Issue 7
©
20
12
 L
an
de
s 
B
io
sc
ie
nc
e.
 D
o 
no
t d
is
tri
bu
te
.
degrading protein aggregates. To answer the possible debate,
we adopted a cell-based functional assay using a GFP-fused
segment of HTT exon1 containing expanded polyglutamine
(mtHTT).19,20 In previous reports on mtHTT in neuronal cell
lines, increased levels of molecular chaperones, such as chaperonin
TRiC and HSP70, and chemical chaperone, 4-PBA, reduced both
mtHTT aggregation and neural cell apoptosis.20,27-29 Comparable
to many cases, DMSO reduced not only soluble but also insoluble
mtHTT expressions, which were masked in the presence of
autophagy inhibitor. From these results, it is plausible that
DMSO might affect various types of autophagy.
There is a limitation to this study. We did not demonstrate
DMSO-induced macrolipophagic effects in an animal model.
In conclusion, DMSO, a kind of chemical chaperone, activates
autophagy by suppressing ATF4 expression and might play a
protective role in the development of free fatty acid-induced
hepatosteatosis. Further investigation is needed to verify the
beneficial roles of chemical chaperones prior to treatment of
patients with hepatosteatosis or NAFLD.
Materials and Methods
Cell culture. Human hepatoma cell line HepG2 cells were grown
at 5% CO2 in Dulbecco’s Modified Eagle’s Medium (DMEM)
(Welgene, LM 001-05) containing antibiotics and 10% fetal calf
serum (Welgene, S101-01).
Figure 5. DMSO-induced autophagy is controlled through ATF4-mediated downregulation of phosphorylated AKT1. Expression of ATF4 and LC3 were
assessed by western blotting and RT-PCR in the presence of siRNA against ATF4. (A and B) ATF4 siRNA were transiently transfected into HepG2 cells with
LipofectAMINE 2000. The level of protein and mRNA expression of ATF4 was suppressed a dose- and time-dependent manner in HepG2 cells treated
with 0.01% DMSO treatment. siRNA-transfected HepG2 cells were treatment 0.5 mM palmitate in the absence or presence of 0.01% DMSO for 6 h.
(C) Knockdown of ATF4 expression significantly increased mRNA and protein expression of LC3 (D, left panel). And right panel of (D) indicated autophagic
flux assays in the absence or presence of 50 nM CQ. The expression of LC3-II was further increased than by siATF4 alone. The experiments were
performed five times under identical conditions. Results are shown as mean ± SEM *p , 0.05, **p , 0.01, ***p , 0.001 vs. untreated control cells.
(E) Knockdown of ATF4 expression using siRNA suppressed ATF4 expression and phosphorylation of AKT1, MTOR and RPS6KB2, but increased LC3-II
conversion. The experiments were performed four times under identical conditions. Results are shown as mean ± SEM *p , 0.05, **p , 0.01,
***p , 0.001 vs. palmitate-treated cells, ††p , 0.01, †††p , 0.001 vs. palmitate and si-ATF4-treated cells, 44p , 0.01, 444p , 0.001 vs. palmitate and DMSO-
treated cells. To demonstrate the attenuation of the palmitate-induced lipid accumulation by the knockdown of ATF4, lipid accumulation was
determined by fat quantization in the presence of siRNA against ATF4. Scramble siRNA and ATF4 siRNA were transiently transfected into HepG2 cells with
LipofectAMINE 2000. (F) Transfected HepG2 cells were treated palmitae for 6 h. siRNA against ATF4 statistically decreased palmitate-induced lipid
accumulation. The experiments were performed four times under identical conditions. *p, 0.05, ***p, 0.001 vs. untreated control cells, †††p, 0.001 vs.
scramble RNA-treated cells, 444p , 0.001 vs. siATF4-treated cells, ∫∫∫p , 0.001 vs. palmitate-treated cells.
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Free fatty acid (FFA) preparation. FFA solutions were prepared
as described in reference.30 Briefly, 100 mM palmitate (Sigma,
P9767) stocks were prepared in 0.1 M NaOH at 70°C and
filtered. One percent (weight/volume) palmitate-free BSA (Sigma,
A2153) solution was prepared in serum-free DMEM. After the
palmitate dissolved, the palmitate solutions were added to serum-
free DMEM containing BSA. The 5 mM palmitate/1% BSA
solution was prepared by complexing appropriate amounts of
palmitate to 1% BSA in a 40°C water bath.
Cell proliferation assessed by MTT. HepG2 cells were
dispensed in wells of 24-well plates at a density of 5 
104 cells/well. HepG2 cells were pre-treated with various
concentration of DMSO (0.01, 0.05, 0.1, 0.5 and 1.0%) for
16 h and then the cells were incubated in the presence of 0.5 mM
palmitate for 24 h. The cells were then treated with 0.5 mg/ml
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) (Sigma, M5655) for 4 h at 37°C and then dissolved in
250 ml DMSO. After 30 min at room temperature, absorbance
Figure 5E and F. See previous page for figure legend.
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was measured at 570 nm using a micro-plate reader (Molecular
Devices).
Fat quantization by Oil Red O staining and triglyceride
determination. Lipid droplets were visualized by Oil Red O
(Sigma, O0625) staining. After treatment with 0.5 mM palmitate
in the presence or absence of 0.01% DMSO, the cells were fixed
with 10% formalin for 1 h and then stained in pre-warmed Oil
Red O solution for 1 h in a 60°C water bath. The red-stained lipid
droplets were observed under a light microscope. To measure the
quantification of lipid accumulation, Oil Red O was eluted by
adding 100% isopropanol and optical density was detected using a
spectrophotometer at 520 nm. Triglyceride levels in cells were
determined using a triglyceride measurement kit (BioVision,
K622-100) following the guideline provided by the company.
Detection of autophagy. In this study, autophagy was then
induced in cells, which were maintained with complete medium
by adding 0.005% and 0.01% DMSO for 8 to 24 h
supplemented with 5% FBS. Autophagy was determined by (1)
detection of autophagic flux, autophagosome substrates SQSTM1
and the specific processing of the autophagy protein LC3 with or
without a 50 mM lysosomal protease inhibitor, chloroquine,
(Sigma, C6628) by western blot analysis31; (2) detection of
autophagosomes with GFP-LC3 marker by fluorescence micro-
scopy (GFP-LC3 punctate assay); and (3) detection of auto-
phagosomes and autolysosomes using transmission electron
microscopic assay. For the GFP-LC3 punctate assay, HepG2
cells were transfected with plasmids expressing GFP-LC3
(ORIGINE, RC100021). Twenty-four hours after treatment
Figure 6. The aggregation of polyglutamine was reduced by DMSO-induced autophagy. (A) Aggregates of pHTTex120Q-GFP (mtHTT), assessed by
fluorescence microscopic assay, were formed by transfection of mtHTT into HepG2 cells using Lipofectamin 2000. HepG2 cells transfected with either
pHTTex120Q-GFP (mtHTT) or pcDNA for 20 h were treated with 0.00 to 0.02% DMSO for 16 h. Cell lysates were prepared, separated into soluble and
insoluble fractions and performed using western blotting with anti-GFP or anti-actin antibody. (B) The soluble and insoluble mtHTT expressions were
attenuated by the treatment of DMSO but not in the presence of 3MA. The expressions of SQSTM1 were also significantly decreased. The experiments
were performed five times under identical conditions. *p , 0.05, ***p , 0.001 vs. untreated control cells in the absence of 3MA, †p , 0.05, †††p , 0.001
vs. untreated control cells in the presence of 3MA.
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with 0.01% DMSO, these cells were fixed with 4% para-
formaldehyde and were then observed under a fluorescence
microscope. Cells were classified as having a predominantly
diffuse GFP stain or having numerous punctate structures
representing autophagosomes. At least 30 cells were scored in
each of two independent experiments.32 In addition, HepG2 cells
were also co-infected with both GFP-LC3 and RFP-LAMP1
(lysosome associated membrane protein 1-tagged with red
fluorescent protein) and then treated with 0.01% DMSO for
16 h. Fluorescence microscopy showed RFP-LAMP1 colocalized
with GFP-LC3 in the cytoplasm. For detection of auto-
phagosomes using electron microscopic assay, 0.01% DMSO
treated-HepG2 cells were fixed with 2% glutaraldehyde-2%
paraformaldehyde buffered with 0.1 M phosphate buffer (pH 7.2)
overnight at 4°C, post-fixed with 1% osmium tetroxide in a 0.1M
sodium cacodylate buffer (pH 7.4) for 1 h at room temperature,
and were dehydrated with a graded series of ethanol. The
dehydrated pellets were then embedded in Epon.
Immunoblotting. Cells were lysed in PRO-PREPTM
(iNtRON biotechnology, 17081). Whole cell lysates were
resolved by SDS-PAGE, electroblotted onto a nitrocellulose
membrane (BIO-RAD, 162-0115), and probed with the
indicated antibodies. Horseradish peroxidase-conjugated anti-
rabbit (Santa Cruz Biotechnology, SC-2004) or anti-mouse
secondary antibodies (Santa Cruz Biotechnology, SC-2005) were
used along with the ECL Plus system (Amersham Biosciences,
RPN2132) to visualize immunoreactive bands.33 Proteins
were detected using the following primary antibodies: LC3B
(Cell Signaling Technology, 2275), ATF4 (Santa Cruz
Biotechnology, C-20), HSPA5 (Abcam, ab21685), p-EIF2AK3
(Santa Cruz Biotechnology, SC-32577), p-EIF2S1 (Cell Signaling
Technology, 3597), ATF6 (Abcam, ab11909), p-ERN1 (Santa
Cruz Biotechnology, SC-20790), sXbp1 (BioLegend, 619502),
DDIT3 (Santa Cruz Biotechnology, SC-575), AKT1 (Cell
Signaling Technology, 4691), phospho-AKT1 (Cell Signaling
Technology, 4060), phospho-MTOR (Cell Signaling Technology,
2971), phopho-RPS6KB2 (Cell Signaling Technology, 9208), GFP
(Cell Signaling Technology, 2956), SQSTM1 (Cell Signaling
Technology, 5114) and actin (Santa Cruz Biotechnology, SC-
47778) were used as primary antibodies.
RNA extraction and RT-PCR. Total cellular RNA was
extracted using TRIzol reagent (Invitrogen, 15596-018) according
to the manual sheets provided with the product. SuperScript III
First-Strand kit (Invitrogen, 18080-051) was used to perform
cDNA synthesis. The primer sequences used for amplification
were as follows: ATF4 forward primer, 5'- GGCCACCATGGC
GTATTA-3'; reverse primer, 5'-TGCTGAATGCCGTGAGAA-3';
GAPDH forward primer, 5'-ATCACTGCCACCCAGAAGAC-3';
and reverse primer, 5'-ATGAGGTCCACCACCCTGTT-3'; LC3
forward primer, 5'-AGACCTTCAA GCAGCGCCG -3', reverse
primer, 5'-ACACTGACAATTTCATCCCG-3'. The temperature
profile was at 94°C for 5 min, followed by 25–27 cycles at 94°C
for 45 sec, 55°C for 30 sec and 72°C for 30 sec. The numbers of
PCR amplification cycles for ATF4, LC3 and GAPDH were 27,
30 and 25 respectively. PCR reactions in final PCR products were
determined in DNA agarose 2% gels.
Small interfering RNA-mediated knockdown of ATF4
expression. Validated ATF4 small interfering RNA (siRNA)
and negative control siRNA were purchased from Santa-Cruz
Biotechnology (Santa-Cruz Biotechnology, SC-35112). siRNAs
and LipofectAMINE 2000 (Invitrogen, 11668-027) were
diluted into Opti-MEM I reduced serum medium (Invitrogen,
51985034) according to the manufacturer’s protocol. HepG2
cells were incubated for 16 h with a tranfection mixture at a
final RNA concentration of 50 pmol and then supplemented
with fresh medium. Cells were then subjected to western
blot analysis.
Decrease of aggregated polyglutamine by treatment with
DMSO. Green fluorescent protein (GFP)-fused segment of HTT
exon1 containing expanded polyglutamine (n = 120) were kindly
provided by Prof. Jung YK.19 HepG2 cells were transfected with
pHTTex120Q-GFP (mtHTT) using Lipofectamin 2000 accord-
ing to the manufacturer’s protocol. Cells were then observed
under fluorescence microscope to evaluate the amount of
mtHTT. Cells were lyzed with sampling buffer (10% glycerol,
2% SDS, 62.5 mM Tris–HCl, 2% b-mercaptoethanol, pH 6.8).
For preparation of insoluble fractions, cells were lysed with lysis
buffer (0.1% Nonidet P-40, 250 mM NaCl, 5 mM EDTA,
50 mM Hepes, pH 7.4) and subjected to centrifugation at 400 g
for 3 min. The pellets were resuspended in a volume of lysis buffer
equal to the volume of the supernatant as described.19
Statistical analysis. Statistical analysis was performed using
PRISM (GraphPad Software Inc.). Results are expressed as mean
± SD. Statistical significance was calculated using Student’s t-test,
or for comparisons involving more than two groups, one-way
analysis of variance (ANOVA) with a post hoc Bonferroni
multiple comparison test being used to assess the differences
between the groups. Statistical significance was defined as the
conventional p value of , 0.05.
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